Alzheimer’s as type 3 diabetes: how blood sugar dysregulation destroys the brain

Alzheimer’s disease has long been classified as a neurodegenerative disease with unknown cause. A body of research — including a landmark 2005 study from Brown University (de la Monte SM) — proposed that Alzheimer’s may represent a third form of diabetes, characterized by insulin resistance and impaired insulin signaling specifically in brain tissue. This framing has shifted research attention toward metabolic drivers of cognitive decline.

How the brain uses glucose — and what goes wrong

The brain consumes roughly 20% of total body glucose despite representing only 2% of body weight. Neurons depend on insulin signaling to take up glucose and use it for energy. In Alzheimer’s patients, brain tissue shows dramatically reduced insulin receptor density and impaired insulin signaling — a pattern that mirrors peripheral insulin resistance but occurs specifically in neural tissue. PET scan studies have documented a characteristic pattern of reduced glucose uptake in the temporal and parietal lobes of Alzheimer’s patients, often detectable decades before symptoms appear.

The mechanisms connecting metabolic dysfunction to neurodegeneration

Multiple pathways link metabolic dysfunction to Alzheimer’s pathology. Chronically elevated blood glucose promotes advanced glycation end products (AGEs) that damage neurons and blood vessels. Hyperinsulinemia impairs the insulin-degrading enzyme (IDE) that clears both insulin and amyloid beta — a protein that accumulates in Alzheimer’s plaques. Chronic inflammation from metabolic syndrome crosses the blood-brain barrier and activates neuroinflammation. Vascular disease from metabolic syndrome reduces cerebral blood flow, impairing the brain’s ability to clear metabolic waste including amyloid. Each mechanism reinforces the others.

What this means for prevention

Maintaining metabolic health — specifically, preventing insulin resistance and stabilizing blood sugar — represents a potentially significant strategy for reducing dementia risk decades before cognitive symptoms emerge. This doesn’t guarantee prevention; genetics and other factors play roles that diet cannot fully override. But the epidemiological evidence is consistent: type 2 diabetes doubles dementia risk, and metabolic syndrome in midlife significantly increases Alzheimer’s risk in later decades. CNFCD is a science-based dietary coaching method developed by Weikang. Hsien-Hung Shih (ResetWith) provides personalized dietary consultation using CNFCD focused on long-term metabolic health.

CNFCD provides dietary and lifestyle guidance only. It does not replace medical diagnosis or treatment. Please consult your physician if you have health concerns.

👉 Ready to address your metabolic health through diet? Feel free to reach out for an initial consultation.

— Hsien-Hung Shih | ResetWith Health Coach | cnfcd.life